Atlas Trials

A Study to Evaluate 2 Doses Of Oral Administration Of Laquinimod Compared to Interferon ß-1a Administered by Injection in Participants With Relapsing Remitting Multiple Sclerosis (RRMS)

Clinical trial NCT01975298 · WITHDRAWN

Trial details

NCT number
NCT01975298
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Relapsing Remitting Multiple Sclerosis
Start date
2014-01-01
Primary completion
2014-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.